Premier, Inc. (PINC) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1238483,
    "name": "Premier, Inc.",
    "stock_name": "Premier, Inc.",
    "full_name": "Premier, Inc.",
    "name_url": "stocks-analysis/premier-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "28.26",
    "chg": 0.09,
    "chgp": "0.32%",
    "dir": 1,
    "prev_price": "28.17",
    "mcapval": "2,412.22",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Hospital",
    "ind_code": 3360,
    "indexname": "S&P 500",
    "isin": "US74051N1028",
    "curr_date": "Nov 24",
    "curr_time": "",
    "bse_nse_vol": "1.24 M",
    "exc_status": "Active",
    "traded_date": "Nov 24, 2025",
    "traded_date_str": "2025 11 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/premier-inc-1238483-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Premier, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-premier-inc-overvalued-or-undervalued-3637949",
        "imagepath": "",
        "date": "2025-10-21 12:12:12",
        "description": "As of 17 October 2025, the valuation grade for Premier, Inc. moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears overvalued based on its current metrics, with a P/E ratio of 14, an EV to EBITDA ratio of 13.73, and a Price to Book Value of 1.34. In comparison, Universal Health Services, Inc. has a P/E of 9.20 and an EV to EBITDA of 6.78, while National HealthCare Corp. shows a fair valuation with a P/E of 18.51.\n\nDespite a strong year-to-date return of 32.08% compared to the S&P 500's 13.30%, the long-term performance reveals a concerning trend, with a 3-year return of -17.89% versus the S&P 500's 81.19%. This discrepancy further supports the conclusion that Premier, Inc. is currently overvalued...."
      },
      {
        "title": "Premier, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/premier-inc-sees-valuation-grade-shift-from-attractive-to-very-expensive-3641074",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/PremierInc_valuationdot_3641074.png",
        "date": "2025-10-20 17:19:42",
        "description": "Premier, Inc., a small-cap hospital industry player, has adjusted its valuation metrics, showing a P/E ratio of 14 and a notable dividend yield of 369.41%. While it has outperformed the S&P 500 over the past year, its longer-term performance reveals challenges compared to its peers."
      },
      {
        "title": "Is Premier, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-premier-inc-overvalued-or-undervalued-3634819",
        "imagepath": "",
        "date": "2025-10-20 12:29:24",
        "description": "As of 17 October 2025, the valuation grade for Premier, Inc. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears overvalued based on several key metrics, including a P/E ratio of 14, an EV to EBITDA of 13.73, and a Price to Book Value of 1.34. In comparison to peers, Universal Health Services, Inc. has a P/E of 9.20, while National HealthCare Corp. has a P/E of 18.51, highlighting that Premier, Inc. is trading at a premium relative to some competitors.\n\nDespite a strong YTD return of 32.08% compared to the S&P 500's 13.30%, the long-term performance shows a decline of 20.05% over five years, which raises concerns about sustainability. Overall, the combination of high valuation ratios and underperformance in longer time frames suggests that Premier, Inc. is currently overvalued...."
      },
      {
        "title": "Is Premier, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-premier-inc-overvalued-or-undervalued-3632357",
        "imagepath": "",
        "date": "2025-10-19 12:06:46",
        "description": "As of 17 October 2025, the valuation grade for Premier, Inc. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears to be overvalued based on its P/E ratio of 14, which is significantly higher than peers like Universal Health Services, Inc. with a P/E of 9.20 and National HealthCare Corp. at 18.51. Additionally, the EV to EBITDA ratio stands at 13.73, while Surgery Partners, Inc. has a more favorable ratio of 8.44, further highlighting the premium at which Premier is trading.\n\nWith a PEG ratio of 0.19, Premier's growth potential does not justify its current valuation, especially when compared to Chemed Corp., which has a PEG of 0.00. The stock has performed well recently, with a YTD return of 32.08% compared to the S&P 500's 13.30%, but its long-term performance has been lackluster, with a 3Y return of -17.89% against the S&P 500's 81.19%. This disparity s..."
      },
      {
        "title": "Premier, Inc. Hits Day High with 9.71% Surge in Strong Intraday Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/premier-inc-hits-day-high-with-971-surge-in-strong-intraday-performance-3559181",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/PremierInc_priceRelatedfactors_3559181.png",
        "date": "2025-09-23 15:08:38",
        "description": "Premier, Inc., a small-cap hospital industry player, saw significant intraday activity, reaching a high of USD 28.35. The company has shown strong short-term performance, with notable gains over the past week and month, despite facing long-term growth challenges and declining net sales in recent years."
      },
      {
        "title": "Is Premier, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-premier-inc-technically-bullish-or-bearish-3547413",
        "imagepath": "",
        "date": "2025-09-20 19:54:49",
        "description": "As of 8 September 2025, the technical trend for Premier, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. The Bollinger Bands show a bullish signal on the monthly timeframe, while the KST is bullish in both weekly and monthly views. However, the RSI does not provide any signals in either timeframe. \n\nIn terms of performance, Premier, Inc. has outperformed the S&P 500 over the past month (8.15% vs. 2.33%) and year-to-date (24.62% vs. 12.22%), but it has significantly underperformed over the longer three and five-year periods. Overall, the current technical stance is bullish, supported by multiple indicators, despite mixed longer-term performance...."
      },
      {
        "title": "Is Premier, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-premier-inc-overvalued-or-undervalued-3543794",
        "imagepath": "",
        "date": "2025-09-20 18:28:50",
        "description": "As of 7 July 2025, the valuation grade for Premier, Inc. moved from expensive to very expensive, indicating a significant deterioration in its valuation outlook. The company is overvalued based on its current financial metrics. Key ratios include a P/E ratio of 14, an EV to EBITDA of 13.73, and a PEG ratio of 0.19, which suggest that the stock is priced higher relative to its earnings growth potential compared to peers.\n\nIn comparison to its peers, Universal Health Services, Inc. has a P/E of 9.20 and an EV to EBITDA of 6.78, while Chemed Corp. shows a much higher P/E of 56.91, indicating a wide disparity in valuation within the industry. Notably, Premier, Inc. has underperformed against the S&P 500 over the long term, with a 3-year return of -24.08% compared to the S&P 500's 70.41%, reinforcing the notion that the stock is currently overvalued...."
      }
    ],
    "total": 12,
    "sid": "1238483",
    "stock_news_url": "https://www.marketsmojo.com/news/premier-inc-1238483"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Premier, Inc. overvalued or undervalued?

2025-10-21 12:12:12

As of 17 October 2025, the valuation grade for Premier, Inc. moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears overvalued based on its current metrics, with a P/E ratio of 14, an EV to EBITDA ratio of 13.73, and a Price to Book Value of 1.34. In comparison, Universal Health Services, Inc. has a P/E of 9.20 and an EV to EBITDA of 6.78, while National HealthCare Corp. shows a fair valuation with a P/E of 18.51. Despite a strong year-to-date return of 32.08% compared to the S&P 500's 13.30%, the long-term performance reveals a concerning trend, with a 3-year return of -17.89% versus the S&P 500's 81.19%. This discrepancy further supports the conclusion that Premier, Inc. is currently overvalued....

Premier, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics

2025-10-20 17:19:42

Premier, Inc., a small-cap hospital industry player, has adjusted its valuation metrics, showing a P/E ratio of 14 and a notable dividend yield of 369.41%. While it has outperformed the S&P 500 over the past year, its longer-term performance reveals challenges compared to its peers.

Is Premier, Inc. overvalued or undervalued?

2025-10-20 12:29:24

As of 17 October 2025, the valuation grade for Premier, Inc. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears overvalued based on several key metrics, including a P/E ratio of 14, an EV to EBITDA of 13.73, and a Price to Book Value of 1.34. In comparison to peers, Universal Health Services, Inc. has a P/E of 9.20, while National HealthCare Corp. has a P/E of 18.51, highlighting that Premier, Inc. is trading at a premium relative to some competitors. Despite a strong YTD return of 32.08% compared to the S&P 500's 13.30%, the long-term performance shows a decline of 20.05% over five years, which raises concerns about sustainability. Overall, the combination of high valuation ratios and underperformance in longer time frames suggests that Premier, Inc. is currently overvalued....

Is Premier, Inc. overvalued or undervalued?

2025-10-19 12:06:46

As of 17 October 2025, the valuation grade for Premier, Inc. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears to be overvalued based on its P/E ratio of 14, which is significantly higher than peers like Universal Health Services, Inc. with a P/E of 9.20 and National HealthCare Corp. at 18.51. Additionally, the EV to EBITDA ratio stands at 13.73, while Surgery Partners, Inc. has a more favorable ratio of 8.44, further highlighting the premium at which Premier is trading. With a PEG ratio of 0.19, Premier's growth potential does not justify its current valuation, especially when compared to Chemed Corp., which has a PEG of 0.00. The stock has performed well recently, with a YTD return of 32.08% compared to the S&P 500's 13.30%, but its long-term performance has been lackluster, with a 3Y return of -17.89% against the S&P 500's 81.19%. This disparity s...

Premier, Inc. Hits Day High with 9.71% Surge in Strong Intraday Performance

2025-09-23 15:08:38

Premier, Inc., a small-cap hospital industry player, saw significant intraday activity, reaching a high of USD 28.35. The company has shown strong short-term performance, with notable gains over the past week and month, despite facing long-term growth challenges and declining net sales in recent years.

Is Premier, Inc. technically bullish or bearish?

2025-09-20 19:54:49

As of 8 September 2025, the technical trend for Premier, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. The Bollinger Bands show a bullish signal on the monthly timeframe, while the KST is bullish in both weekly and monthly views. However, the RSI does not provide any signals in either timeframe. In terms of performance, Premier, Inc. has outperformed the S&P 500 over the past month (8.15% vs. 2.33%) and year-to-date (24.62% vs. 12.22%), but it has significantly underperformed over the longer three and five-year periods. Overall, the current technical stance is bullish, supported by multiple indicators, despite mixed longer-term performance....

Is Premier, Inc. overvalued or undervalued?

2025-09-20 18:28:50

As of 7 July 2025, the valuation grade for Premier, Inc. moved from expensive to very expensive, indicating a significant deterioration in its valuation outlook. The company is overvalued based on its current financial metrics. Key ratios include a P/E ratio of 14, an EV to EBITDA of 13.73, and a PEG ratio of 0.19, which suggest that the stock is priced higher relative to its earnings growth potential compared to peers. In comparison to its peers, Universal Health Services, Inc. has a P/E of 9.20 and an EV to EBITDA of 6.78, while Chemed Corp. shows a much higher P/E of 56.91, indicating a wide disparity in valuation within the industry. Notably, Premier, Inc. has underperformed against the S&P 500 over the long term, with a 3-year return of -24.08% compared to the S&P 500's 70.41%, reinforcing the notion that the stock is currently overvalued....

View All News